Last reviewed · How we verify

NCT02625896: ACROPOSE

Free Fall Acrobatics to Reduce Neck Loads During Parachute Opening Shock: Evaluation of an Intervention.

Completed NA Last updated 30 October 2018
What this trial tests

NA trial testing Intervention in Pain in 16 participants. Completed in 14 October 2018.

Timeline
17 June 2017
Primary endpoint
14 October 2018
14 October 2018

Quick facts

Lead sponsorKarolinska Institutet
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment16
Start date17 June 2017
Primary completion14 October 2018
Estimated completion14 October 2018
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 18 to 60, any sex, with Pain or Athletic Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the use of an aerial human body manoeuvre to reduce the biomechanical load on the neck of a parachutist during the parachute opening, in order to create a basis for future prevention of skydiver neck pain in the parachutist population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Free Fall Acrobatics to Reduce Neck Loads During Parachute Opening Shock: Evaluation of an Intervention (ACROPOSE).
    Westman A, Äng BO. · · 2016 · PMID 27900175 · DOI 10.1136/bmjsem-2015-000108

Verify or expand the search:

Other trials of Intervention

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02625896.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing